LPL Financial’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.91M | Sell |
52,975
-16,166
| -23% | -$582K | ﹤0.01% | 3150 |
|
|
2025
Q1 | $2.15M | Buy |
69,141
+45,236
| +189% | +$1.41M | ﹤0.01% | 2873 |
|
|
2024
Q4 | $610K | Sell |
23,905
-2,859
| -11% | -$72.9K | ﹤0.01% | 3866 |
|
|
2024
Q3 | $757K | Sell |
26,764
-18,294
| -41% | -$518K | ﹤0.01% | 3604 |
|
|
2024
Q2 | $1.19M | Buy |
45,058
+16,207
| +56% | +$427K | ﹤0.01% | 3056 |
|
|
2024
Q1 | $876K | Buy |
28,851
+8,327
| +41% | +$253K | ﹤0.01% | 3271 |
|
|
2023
Q4 | $577K | Buy |
20,524
+5,241
| +34% | +$147K | ﹤0.01% | 3518 |
|
|
2023
Q3 | $415K | Sell |
15,283
-3,555
| -19% | -$96.5K | ﹤0.01% | 3603 |
|
|
2023
Q2 | $579K | Buy |
18,838
+296
| +2% | +$9.1K | ﹤0.01% | 3288 |
|
|
2023
Q1 | $668K | Buy |
18,542
+10,984
| +145% | +$396K | ﹤0.01% | 3098 |
|
|
2022
Q4 | $299K | Sell |
7,558
-2,337
| -24% | -$92.4K | ﹤0.01% | 3632 |
|
|
2022
Q3 | $398K | Buy |
9,895
+763
| +8% | +$30.7K | ﹤0.01% | 3335 |
|
|
2022
Q2 | $384K | Buy |
9,132
+2,201
| +32% | +$92.6K | ﹤0.01% | 3409 |
|
|
2022
Q1 | $270K | Sell |
6,931
-789
| -10% | -$30.7K | ﹤0.01% | 3629 |
|
|
2021
Q4 | $308K | Buy |
+7,720
| New | +$308K | ﹤0.01% | 3653 |
|
|
2021
Q1 | – | Sell |
-5,694
| Closed | -$285K | – | 4108 |
|
|
2020
Q4 | $285K | Sell |
5,694
-14,056
| -71% | -$704K | ﹤0.01% | 3231 |
|
|
2020
Q3 | $831K | Buy |
19,750
+10,867
| +122% | +$457K | ﹤0.01% | 2079 |
|
|
2020
Q2 | $431K | Buy |
+8,883
| New | +$431K | ﹤0.01% | 2511 |
|